JGSBiopharma Ltd
Registered number: 08801963
Balance Sheet
as at 31 December 2023
2023 2022
£ £
Current assets 119,194 194,380
Prepayments and accrued income 55 12
119,249 194,392
Creditors: amounts falling due within one year (2,892) (2,630)
Net current assets 116,357 191,762
Total assets less current liabilities 116,357 191,762
Accruals and deferred income (1,996) (31,890)
Net assets 114,361 159,872
Capital and reserves 114,361 159,872
Number Number
Average number of employees 2 2
Other creditors includes a loan from the directors to the company of £2,892 (2022 £2,373). During the year the company paid rent of £312 (2022 £312) to the directors for use of home office space.
The company is a private company limited by shares and incorporated in England. Its registered office is 10 Wellington Street, Cambridge, CB1 1HW.
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
John Shields
Director
Approved by the board on 27 June 2024
JGSBiopharma Ltd 08801963 false 2023-01-01 2023-12-31 2023-12-31 VT Final Accounts April 2024 John Shields No description of principal activity 08801963 2022-01-01 2022-12-31 08801963 core:WithinOneYear 2022-12-31 08801963 2023-01-01 2023-12-31 08801963 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 08801963 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 08801963 countries:England 2023-01-01 2023-12-31 08801963 bus:Director40 2023-01-01 2023-12-31 08801963 bus:Micro-entities 2023-01-01 2023-12-31 08801963 bus:FilletedAccounts 2023-01-01 2023-12-31 08801963 2023-12-31 08801963 core:WithinOneYear 2023-12-31 08801963 2022-12-31 iso4217:GBP xbrli:pure